http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a185c2b603f497534ed7c01d4d06a0a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Siveke |
| name | Jens T. Siveke Jens T Siveke |
| given-name | Jens T. Jens T |
| organization-name | 1Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 2Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 4Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 7German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany Department of Internal Medicine, Technical University of Munich, Ismaniger Strasse 22, 81675 Munich, Germany. Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany; German Cancer Consortium (DKTK, Partner Site Essen) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany Department of Internal Medicine, University Hospital Essen, Essen, Germany 2Department of Internal Medicine II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.; 4Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; 5German Cancer Consortium (DKTK), partner site Essen and German Cancer Research Center (DKFZ), Heidelberg, Germany. Authors' Affiliations: 1Signaling and Transcription Laboratory, Department of Gastroenterology, Philipps University, Marburg; 2Department of Gastroenterology and Gastrointestinal Oncology, University Medical Center Göttingen, Göttingen; 3II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität; 4Institute of Pathology, Helmholtz Zentrum, Munich; 5Theodor Boveri Institute, University of Würzburg, Würzburg; 6Institute for Genetics, Justus-Liebig-University, Giessen, Germany; 7Schulze Center for Novel Therapeutics, Division of Oncology Research; Divisions of 8Anatomic Pathology and 9Biostatistics, College of Medicine; 10Laboratory of Epigenetics and Chromatin Dynamics, Department of Medicine, Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota; 11Barrow Brain Tumor Research Center, St. Joseph's Hospital and Medical Center, Phoenix, Arizona; and 12Cold Spring Harbor Laboratory, Cold Spring Harbor, New York Division of Solid Tumor Translational Oncology, West German Cancer Center University Hospital Essen Essen Germany; German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center (DKFZ) Heidelberg Germany Department of Internal Medicine, Technical University of Munich, 81675 Munich, Germany. 1Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; 2German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.; 4Medical Department, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. 12. Medizinische Klinik, Technische Universität München, Munich, Germany.; 7German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; 8Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK) Partner Site Essen, West German Cancer Center, University Hospital Essen, Essen, Germany. 2nd Department of Internal Medicine; Klinikum rechts der Isar, Technical University of Munich; Munich Germany II. Medizinische Klinik,Technische Universität München,München,Germany German Consortium for Translational Cancer Research (DKTK), partner location University Hospital Essen, University Hospital Essen, Germany Klinikum rechts der Isar, Technische Universität München, Munich, Germany Second Department of Internal Medicine and II. Medizinische Klinik, Klinikum rechts der Isar Technische Universität München Munich Germany; Brückeninstitut für Experimentelle Tumortherapie Westdeutsches Tumorzentrum, Universitätsklinikum Essen Essen Germany; Abteilung für Translationale Onkologie Solider Tumore, Deutsches Konsortium für Translationale Krebsforschung (DKTK) Parnterstandort Essen Germany; Deutsches Krebsforschungszentrum (DKFZ) Heidelberg Germany Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Hospital Essen , Essen , Germany; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ , Heidelberg , Germany Authors' Affiliations: Departments of 1Internal Medicine III, 2Pathology, and 3Internal Medicine II; and 4Institute for Medical Statistics and Epidemiology, Technische Universitat Munchen, Ismaninger Strasse 22, Munich, Germany; and 5Department of Pathology, University of Tubingen, Liebermeisterstrasse 8, Tubingen, Germany German Cancer Consortium (DKTK), Partner site University Hospital Essen Essen Germany; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center and Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), University Hospital Essen, University Duisburg‐Essen Essen Germany; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ Heidelberg Germany II. Medizinische Klinik und Poliklinik, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany 3Department of Medicine II, Klinikum rechts der Isar, TU München, Munich, Germany. Brückeninstitut für Experimentelle Tumortherapie (BIT), Westdeutsches Tumorzentrum, Universitätsklinikum Essen, Essen, Deutschland. [email protected]. Abteilung für Translationale Onkologie Solider Tumore, Deutsches Konsortium für Translationale Krebsforschung (DKTK) und Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland. [email protected]. Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany Bridge Institute of Experimental Tumor Therapy West German Cancer Center University Hospital of Essen University of Duisburg‐Essen Essen Germany; Division of Solid Tumor Translational Oncology German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center DKFZ Heidelberg Germany Department of Medical Oncology and Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK/DKFZ, partner site Essen), West German Cancer Center, University Hospital Essen , Essen , Germany 32nd Medical Department, Klinikum rechts der Isar, Technische Universität München, Germany.; 4German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; 5Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), partner site Essen, University Hospital Essen, Essen, Germany. Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany; Division of Solid Tumor Translational Oncology, German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany Institute for Developmental Cancer Therapeutics, West German Cancer Center, University Medicine Essen, Essen, Germany; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, Partner Site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany Bridge Institute of Experimental Tumor Therapy, West German Cancer Center University Hospital Essen, University of Duisburg‐Essen Essen Germany; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ Heidelberg Germany Department of Internal Medicine II, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site Essen and German Cancer Research Center (DKFZ), Heidelberg, Germany Bridge Institute of Experimental Tumour Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany; Division of Solid Tumour Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany |
Incoming Links
Showing number of triples: 1 to 155 of 155.